---
schema_version: "secwatch.filing_event.v1"
accession: "0000078003-24-000155"
form_type: "8-K"
ticker: "PFE"
cik: "0000078003"
company_name: "PFIZER INC"
filed_at: "2024-07-30T23:59:59+00:00"
generated_at: "2026-05-31T15:31:46.397729+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Pfizer Q2 adj EPS $0.60, revenue $13.3B; raises FY2024 guidance

## Summary
- Revenues $13.3B, +2% YoY (+3% operational); non-COVID revenue grew 14% operationally.
- Adjusted diluted EPS $0.60, vs $0.67 prior year; includes $1.3B one-time manufacturing optimization costs.
- Raised FY2024 revenue guidance to $59.5-$62.5B (from $58.5-$61.5B) and adjusted EPS to $2.45-$2.65 (from $2.15-$2.35).
- Launched Manufacturing Optimization Program targeting ~$1.5B cost savings by end of 2027; one-time costs ~$1.7B.
- CSO Dr. Mikael Dolsten to depart; successor search underway.

## SEC filing metadata
- accession: 0000078003-24-000155
- form_type: 8-K
- ticker: PFE
- cik: 0000078003
- company_name: PFIZER INC
- filed_at: 2024-07-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/78003/000007800324000155/0000078003-24-000155-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/78003/000007800324000155/pfe-20240730.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000078003-24-000155
- JSON: https://secwatch.observer/filing/0000078003-24-000155.json
- Plain text: https://secwatch.observer/filing/0000078003-24-000155.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.